Yuanyuan Li

机构：Queen Mary University of London, Chinese Academy of Medical Sciences & Peking Union Medical College, Indus Biotech (India), Wangjing Hospital of China Academy of Chinese Medical Sciences, Institute of Aging, Hengyang Academy of Agricultural Sciences, University of South China · ORCID：0000-0002-9143-8029

发表论文 195 篇 · 总被引 10940 次 · h-index 34

代表论文

• A novel nanoparticle vaccine displaying multistage tuberculosis antigens confers protection in mice infected with H37Rv (2025 · npj Vaccines · 被引 10)
• α‑1 Antitrypsin is a potential target of inflammation and immunomodulation (Review) (2025 · Molecular Medicine Reports · 被引 10)
• Inter-species and individualized biotransformation of five saponins by human being- and mouse-derived fecal microbiota (2025 · Chinese Medicine · 被引 7)
• Extreme gradient boosting-based explainable machine learning model for predicting significant fibrosis in autoimmune hepatitis (2025 · QJM · 被引 6)
• Mechanism of Bao Gan Ning decoction in attenuating hepatic fibrosis via modulation of the gut microbiome and PPAR/CYP7A1-mediated bile acid metabolism (2025 · Journal of Ethnopharmacology · 被引 6)
• Notoginsenoside R2 attenuates hepatic fibrosis via STAT3-dependent hepatic stellate cells senescence induction and inflammatory microenvironment suppression (2025 · Journal of Ginseng Research · 被引 5)